U.S. Markets closed

Phathom Pharmaceuticals, Inc. (PHAT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
38.35-0.62 (-1.59%)
At close: 4:00PM EDT

38.35 0.00 (0.00%)
After hours: 4:00PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close38.97
Open39.14
Bid35.00 x 800
Ask42.99 x 800
Day's Range38.00 - 40.58
52 Week Range27.47 - 64.54
Volume53,448
Avg. Volume98,518
Market Cap1.066B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Benzinga

    Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2021

    Upgrades For CVR Energy Inc (NYSE:CVI), Credit Suisse upgraded the previous rating of Underperform to Neutral. In the third quarter, CVR Energy showed an EPS of $0.57, compared to $1.18 from the year-ago quarter. At the moment, the stock has a 52-week-high of $35.63 and a 52-week-low of $9.81. CVR Energy closed at $21.13 at the end of the last trading period. Credit Suisse upgraded the previous rating for Par Pacific Holdings Inc (NYSE:PARR) from Underperform to Neutral. In the third quarter, Par Pacific Hldgs showed an EPS of $1.06, compared to $0.13 from the year-ago quarter. The stock has a 52-week-high of $20.43 and a 52-week-low of $5.72. At the end of the last trading period, Par Pacific Hldgs closed at $15.40. RBC Capital upgraded the previous rating for Bausch Health Companies Inc (NYSE:BHC) from Sector Perform to Outperform. In the third quarter, Bausch Health Cos showed an EPS of $1.32, compared to $1.19 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.25 and a 52-week-low of $11.15. Bausch Health Cos closed at $31.48 at the end of the last trading period. For Black Knight Inc (NYSE:BKI), Susquehanna upgraded the previous rating of Neutral to Positive. Black Knight earned $0.60 in the fourth quarter, compared to $0.54 in the year-ago quarter. The current stock performance of Black Knight shows a 52-week-high of $97.19 and a 52-week-low of $50.01. Moreover, at the end of the last trading period, the closing price was at $82.05. For Anterix Inc (NASDAQ:ATEX), JP Morgan upgraded the previous rating of Neutral to Overweight. At the moment, the stock has a 52-week-high of $57.75 and a 52-week-low of $27.27. Anterix closed at $40.55 at the end of the last trading period. According to Jefferies, the prior rating for Oshkosh Corp (NYSE:OSK) was changed from Hold to Buy. In the first quarter, Oshkosh showed an EPS of $1.13, compared to $1.10 from the year-ago quarter. The stock has a 52-week-high of $100.77 and a 52-week-low of $46.72. At the end of the last trading period, Oshkosh closed at $99.14. For Palantir Technologies Inc (NYSE:PLTR), Goldman Sachs upgraded the previous rating of Neutral to Buy. In the fourth quarter, Palantir Technologies earned $0.06. The current stock performance of Palantir Technologies shows a 52-week-high of $45.00 and a 52-week-low of $8.90. Moreover, at the end of the last trading period, the closing price was at $27.84. KeyBanc upgraded the previous rating for Rexnord Corp (NYSE:RXN) from Sector Weight to Overweight. In the third quarter, Rexnord showed an EPS of $0.39, compared to $0.48 from the year-ago quarter. The current stock performance of Rexnord shows a 52-week-high of $49.08 and a 52-week-low of $18.87. Moreover, at the end of the last trading period, the closing price was at $45.11. According to KeyBanc, the prior rating for Regal Beloit Corp (NYSE:RBC) was changed from Sector Weight to Overweight. For the fourth quarter, Regal Beloit had an EPS of $1.78, compared to year-ago quarter EPS of $1.25. The current stock performance of Regal Beloit shows a 52-week-high of $146.97 and a 52-week-low of $51.99. Moreover, at the end of the last trading period, the closing price was at $133.19. See all analyst ratings upgrades. Downgrades Truist Securities downgraded the previous rating for KAR Auction Services Inc (NYSE:KAR) from Buy to Hold. For the fourth quarter, KAR Auction Services had an EPS of $0.01, compared to year-ago quarter EPS of $0.19. The current stock performance of KAR Auction Services shows a 52-week-high of $23.53 and a 52-week-low of $9.41. Moreover, at the end of the last trading period, the closing price was at $18.45. Roth Capital downgraded the previous rating for Kodiak Sciences Inc (NASDAQ:KOD) from Buy to Neutral. In the third quarter, Kodiak Sciences showed an EPS of $0.80, compared to $0.33 from the year-ago quarter. At the moment, the stock has a 52-week-high of $171.21 and a 52-week-low of $35.49. Kodiak Sciences closed at $145.58 at the end of the last trading period. For KAR Auction Services Inc (NYSE:KAR), Guggenheim downgraded the previous rating of Neutral to Sell. KAR Auction Services earned $0.01 in the fourth quarter, compared to $0.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $23.53 and a 52-week-low of $9.41. KAR Auction Services closed at $18.45 at the end of the last trading period. For Palantir Technologies Inc (NYSE:PLTR), William Blair downgraded the previous rating of Market Perform to Underperform. Palantir Technologies earned $0.06 in the fourth quarter. The stock has a 52-week-high of $45.00 and a 52-week-low of $8.90. At the end of the last trading period, Palantir Technologies closed at $27.84. Morgan Stanley downgraded the previous rating for Fortive Corp (NYSE:FTV) from Overweight to Equal-Weight. For the fourth quarter, Fortive had an EPS of $0.70, compared to year-ago quarter EPS of $1.03. At the moment, the stock has a 52-week-high of $82.12 and a 52-week-low of $37.31. Fortive closed at $69.85 at the end of the last trading period. For Cortexyme Inc (NASDAQ:CRTX), Jefferies downgraded the previous rating of Buy to Hold. In the third quarter, Cortexyme showed an EPS of $0.73, compared to $0.37 from the year-ago quarter. The current stock performance of Cortexyme shows a 52-week-high of $73.84 and a 52-week-low of $26.66. Moreover, at the end of the last trading period, the closing price was at $30.72. JP Morgan downgraded the previous rating for bluebird bio Inc (NASDAQ:BLUE) from Overweight to Neutral. For the third quarter, bluebird bio had an EPS of $2.94, compared to year-ago quarter EPS of $3.73. The stock has a 52-week-high of $90.63 and a 52-week-low of $26.11. At the end of the last trading period, bluebird bio closed at $28.44. See all analyst ratings downgrades. Initiations With an Overweight rating, Wells Fargo initiated coverage on Chesapeake Energy Corp (NASDAQ:CHK). The price target seems to have been set at $54.00 for Chesapeake Energy. The current stock performance of Chesapeake Energy shows a 52-week-high of $77.50 and a 52-week-low of $0.12. Moreover, at the end of the last trading period, the closing price was at $43.55. Roth Capital initiated coverage on DiaMedica Therapeutics Inc (NASDAQ:DMAC) with a Buy rating. The price target for DiaMedica Therapeutics is set to $38.00. For the third quarter, DiaMedica Therapeutics had an EPS of $0.19, compared to year-ago quarter EPS of $0.20. The current stock performance of DiaMedica Therapeutics shows a 52-week-high of $10.88 and a 52-week-low of $1.87. Moreover, at the end of the last trading period, the closing price was at $9.40. Needham initiated coverage on Cormedix Inc (NASDAQ:CRMD) with a Buy rating. The price target for Cormedix is set to $31.00. The stock has a 52-week-high of $17.14 and a 52-week-low of $2.16. At the end of the last trading period, Cormedix closed at $13.99. With an Outperform rating, BMO Capital initiated coverage on Phathom Pharmaceuticals Inc (NASDAQ:PHAT). The price target seems to have been set at $63.00 for Phathom Pharmaceuticals. Phathom Pharmaceuticals earned $1.02 in the third quarter, compared to $1.07 in the year-ago quarter. The stock has a 52-week-high of $64.54 and a 52-week-low of $22.06. At the end of the last trading period, Phathom Pharmaceuticals closed at $42.80. With an Overweight rating, Barclays initiated coverage on IDEXX Laboratories Inc (NASDAQ:IDXX). The price target seems to have been set at $600.00 for IDEXX Laboratories. IDEXX Laboratories earned $1.76 in the fourth quarter, compared to $1.04 in the year-ago quarter. The current stock performance of IDEXX Laboratories shows a 52-week-high of $548.58 and a 52-week-low of $168.65. Moreover, at the end of the last trading period, the closing price was at $538.16. With an Overweight rating, Barclays initiated coverage on Covetrus Inc (NASDAQ:CVET). The price target seems to have been set at $48.00 for Covetrus. For the third quarter, Covetrus had an EPS of $0.26, compared to year-ago quarter EPS of $0.17. The stock has a 52-week-high of $40.77 and a 52-week-low of $4.04. At the end of the last trading period, Covetrus closed at $37.58. With a Buy rating, DA Davidson initiated coverage on First Citizens BancShares Inc (NASDAQ:FCNCA). The price target seems to have been set at $875.00 for First Citizens BancShares. First Citizens BancShares earned $13.59 in the fourth quarter, compared to $9.55 in the year-ago quarter. The current stock performance of First Citizens BancShares shows a 52-week-high of $749.50 and a 52-week-low of $276.08. Moreover, at the end of the last trading period, the closing price was at $746.00. With a Buy rating, HC Wainwright & Co. initiated coverage on Oncolytics Biotech Inc (NASDAQ:ONCY). The price target seems to have been set at $15.00 for Oncolytics Biotech. For the third quarter, Oncolytics Biotech had an EPS of $0.12, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $4.19 and a 52-week-low of $0.94. At the end of the last trading period, Oncolytics Biotech closed at $3.01. Goldman Sachs initiated coverage on Patria Investments Ltd (NASDAQ:PAX) with a Buy rating. The price target for Patria Investments is set to $28.00. The stock has a 52-week-high of $23.28 and a 52-week-low of $17.23. At the end of the last trading period, Patria Investments closed at $22.38. With a Buy rating, BTIG initiated coverage on Vuzix Corporation (NASDAQ:VUZI). The price target seems to have been set at $30.00 for Vuzix. For the third quarter, Vuzix had an EPS of $0.13, compared to year-ago quarter EPS of $0.18. The current stock performance of Vuzix shows a 52-week-high of $17.36 and a 52-week-low of $0.86. Moreover, at the end of the last trading period, the closing price was at $17.16. KeyBanc initiated coverage on Howmet Aerospace Inc (NYSE:HWM) with an Overweight rating. The price target for Howmet Aerospace is set to $36.00. For the fourth quarter, Howmet Aerospace had an EPS of $0.21, compared to year-ago quarter EPS of $0.53. The stock has a 52-week-high of $29.10 and a 52-week-low of $9.87. At the end of the last trading period, Howmet Aerospace closed at $28.37. See all analyst ratings initiations. See more from BenzingaClick here for options trades from BenzingaEarnings Preview: GlobantEarnings Preview for OPKO Health© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Benzinga

    Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2021

    Upgrades According to Summit Insights Group, the prior rating for ON Semiconductor Corp (NASDAQ:ON) was changed from Hold to Buy. For the fourth quarter, ON Semiconductor had an EPS of $0.35, compared to year-ago quarter EPS of $0.30. The current stock performance of ON Semiconductor shows a 52-week-high of $39.43 and a 52-week-low of $8.17. Moreover, at the end of the last trading period, the closing price was at $36.71. Barclays upgraded the previous rating for Dr Reddy's Laboratories Ltd (NYSE:RDY) from Equal-Weight to Overweight. Dr Reddy's Laboratories earned $0.02 in the third quarter, compared to $0.63 in the year-ago quarter. The stock has a 52-week-high of $73.50 and a 52-week-low of $33.33. At the end of the last trading period, Dr Reddy's Laboratories closed at $59.17. For Palo Alto Networks Inc (NYSE:PANW), Credit Suisse upgraded the previous rating of Neutral to Outperform. For the first quarter, Palo Alto Networks had an EPS of $1.62, compared to year-ago quarter EPS of $1.05. The stock has a 52-week-high of $375.00 and a 52-week-low of $125.47. At the end of the last trading period, Palo Alto Networks closed at $361.58. Evercore ISI Group upgraded the previous rating for Tetra Technologies Inc (NYSE:TTI) from Underperform to Outperform. In the third quarter, Tetra Technologies showed an EPS of $0.09, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $1.62 and a 52-week-low of $0.22. Tetra Technologies closed at $1.52 at the end of the last trading period. Goldman Sachs upgraded the previous rating for Dell Technologies Inc (NYSE:DELL) from Neutral to Buy. Dell Technologies earned $2.03 in the third quarter, compared to $1.75 in the year-ago quarter. The current stock performance of Dell Technologies shows a 52-week-high of $77.72 and a 52-week-low of $25.51. Moreover, at the end of the last trading period, the closing price was at $74.00. According to Credit Suisse, the prior rating for Rio Tinto PLC (NYSE:RIO) was changed from Neutral to Outperform. The stock has a 52-week-high of $86.90 and a 52-week-low of $35.35. At the end of the last trading period, Rio Tinto closed at $78.48. See all analyst ratings upgrades. Downgrades Credit Suisse downgraded the previous rating for BHP Group Ltd (NYSE:BHP) from Outperform to Neutral. The current stock performance of BHP Group shows a 52-week-high of $74.41 and a 52-week-low of $29.78. Moreover, at the end of the last trading period, the closing price was at $68.38. For Limelight Networks Inc (NASDAQ:LLNW), Cowen & Co. downgraded the previous rating of Outperform to Market Perform. Limelight Networks earned $0.01 in the third quarter, compared to $0.01 in the year-ago quarter. At the moment, the stock has a 52-week-high of $8.19 and a 52-week-low of $3.43. Limelight Networks closed at $4.67 at the end of the last trading period. Compass Point downgraded the previous rating for Hilltop Holdings Inc (NYSE:HTH) from Buy to Neutral. For the fourth quarter, Hilltop Holdings had an EPS of $1.30, compared to year-ago quarter EPS of $0.54. The current stock performance of Hilltop Holdings shows a 52-week-high of $33.69 and a 52-week-low of $11.05. Moreover, at the end of the last trading period, the closing price was at $30.85. According to Piper Sandler, the prior rating for argenx SE (NASDAQ:ARGX) was changed from Overweight to Neutral. For the third quarter, argenx had an EPS of $3.96, compared to year-ago quarter EPS of $0.72. The current stock performance of argenx shows a 52-week-high of $321.66 and a 52-week-low of $103.75. Moreover, at the end of the last trading period, the closing price was at $317.40. See all analyst ratings downgrades. Initiations Stephens & Co. initiated coverage on Zix Corp (NASDAQ:ZIXI) with an Overweight rating. The price target for Zix is set to $11.00. In the third quarter, Zix showed an EPS of $0.17, compared to $0.13 from the year-ago quarter. The current stock performance of Zix shows a 52-week-high of $9.46 and a 52-week-low of $2.84. Moreover, at the end of the last trading period, the closing price was at $8.32. MKM Partners initiated coverage on Poshmark Inc (NASDAQ:POSH) with a Buy rating. The price target for Poshmark is set to $88.00. The stock has a 52-week-high of $104.98 and a 52-week-low of $67.18. At the end of the last trading period, Poshmark closed at $73.00. Guggenheim initiated coverage on Phathom Pharmaceuticals Inc (NASDAQ:PHAT) with a Buy rating. The price target for Phathom Pharmaceuticals is set to $60.00. For the third quarter, Phathom Pharmaceuticals had an EPS of $1.02, compared to year-ago quarter EPS of $1.07. The stock has a 52-week-high of $64.54 and a 52-week-low of $22.06. At the end of the last trading period, Phathom Pharmaceuticals closed at $38.49. Wells Fargo initiated coverage on Gracell Biotechnologies Inc (NASDAQ:GRCL) with an Overweight rating. At the moment, the stock has a 52-week-high of $28.88 and a 52-week-low of $20.12. Gracell Biotechnologies closed at $21.81 at the end of the last trading period. Morgan Stanley initiated coverage on Stride Inc (NYSE:LRN) with a Equal-Weight rating. The price target for Stride is set to $27.00. The stock has a 52-week-high of $52.84 and a 52-week-low of $15.06. At the end of the last trading period, Stride closed at $27.20. Jefferies initiated coverage on Gracell Biotechnologies Inc (NASDAQ:GRCL) with a Buy rating. The price target for Gracell Biotechnologies is set to $30.00. At the moment, the stock has a 52-week-high of $28.88 and a 52-week-low of $20.12. Gracell Biotechnologies closed at $21.81 at the end of the last trading period. Morgan Stanley initiated coverage on Chart Industries Inc (NYSE:GTLS) with an Overweight rating. The price target for Chart Industries is set to $135.00. Chart Industries earned $0.80 in the third quarter, compared to $0.77 in the year-ago quarter. At the moment, the stock has a 52-week-high of $143.56 and a 52-week-low of $15.00. Chart Industries closed at $127.54 at the end of the last trading period. With an Outperform rating, SVB Leerink initiated coverage on Cullinan Management Inc (NASDAQ:CGEM). The price target seems to have been set at $52.00 for Cullinan Management. The stock has a 52-week-high of $43.00 and a 52-week-low of $27.01. At the end of the last trading period, Cullinan Management closed at $33.77. With a Buy rating, Citigroup initiated coverage on Clover Health Investments Corp (NASDAQ:CLOV). The price target seems to have been set at $19.00 for Clover Health Investments. The stock has a 52-week-high of $17.24 and a 52-week-low of $13.10. At the end of the last trading period, Clover Health Investments closed at $13.81. Stephens & Co. initiated coverage on Mimecast Ltd (NASDAQ:MIME) with an Overweight rating. The price target for Mimecast is set to $57.00. In the second quarter, Mimecast showed an EPS of $0.32, compared to $0.13 from the year-ago quarter. The current stock performance of Mimecast shows a 52-week-high of $59.48 and a 52-week-low of $25.14. Moreover, at the end of the last trading period, the closing price was at $44.45. Stephens & Co. initiated coverage on Proofpoint Inc (NASDAQ:PFPT) with an Overweight rating. The price target for Proofpoint is set to $165.00. For the third quarter, Proofpoint had an EPS of $0.59, compared to year-ago quarter EPS of $0.49. The current stock performance of Proofpoint shows a 52-week-high of $140.91 and a 52-week-low of $83.81. Moreover, at the end of the last trading period, the closing price was at $130.62. Stephens & Co. initiated coverage on Ping Identity Holding Corp (NYSE:PING) with an Overweight rating. The price target for Ping Identity Holding is set to $40.00. For the third quarter, Ping Identity Holding had an EPS of $0.11, compared to year-ago quarter EPS of $0.13. The current stock performance of Ping Identity Holding shows a 52-week-high of $37.80 and a 52-week-low of $12.02. Moreover, at the end of the last trading period, the closing price was at $30.83. With an Outperform rating, Raymond James initiated coverage on Neurocrine Biosciences Inc (NASDAQ:NBIX). The price target seems to have been set at $163.00 for Neurocrine Biosciences. Neurocrine Biosciences earned $0.97 in the third quarter, compared to $0.90 in the year-ago quarter. The stock has a 52-week-high of $136.26 and a 52-week-low of $72.14. At the end of the last trading period, Neurocrine Biosciences closed at $106.02. With an Overweight rating, Piper Sandler initiated coverage on Gracell Biotechnologies Inc (NASDAQ:GRCL). The price target seems to have been set at $40.00 for Gracell Biotechnologies. At the moment, the stock has a 52-week-high of $28.88 and a 52-week-low of $20.12. Gracell Biotechnologies closed at $21.81 at the end of the last trading period. Piper Sandler initiated coverage on Surgalign Holdings Inc (NASDAQ:SRGA) with an Overweight rating. The price target for Surgalign Holdings is set to $4.00. For the third quarter, Surgalign Holdings had an EPS of $0.11, compared to year-ago quarter EPS of $0.01. At the moment, the stock has a 52-week-high of $3.15 and a 52-week-low of $1.49. Surgalign Holdings closed at $1.70 at the end of the last trading period. With an Overweight rating, Piper Sandler initiated coverage on Nevro Corp (NYSE:NVRO). The price target seems to have been set at $190.00 for Nevro. Nevro earned $0.29 in the third quarter, compared to $0.58 in the year-ago quarter. The current stock performance of Nevro shows a 52-week-high of $188.14 and a 52-week-low of $65.05. Moreover, at the end of the last trading period, the closing price was at $163.86. See all analyst ratings initiations. See more from BenzingaClick here for options trades from BenzingaEarnings Outlook For Axalta Coating SystemsA Preview Of KLA's Earnings© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Phathom Pharmaceuticals (PHAT) Surges: Stock Moves 6.9% Higher
    Zacks

    Phathom Pharmaceuticals (PHAT) Surges: Stock Moves 6.9% Higher

    Phathom Pharmaceuticals (PHAT) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.